Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30620787 | 0.86 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL26625926 | 0.86 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL4984709 | 0.77 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL129315 | 0.77 | — | — | |
| SCHEMBL19204512 | 0.76 | PAX8 (0.30) | ALDH1A1 | |
| SCHEMBL929080 | 0.75 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL7776760 | 0.74 | ALDH1A1 (0.37) | ALDH1A1 | |
| Cyanide SCHEMBL28015746 | 0.72 | — | — | |
| SCHEMBL26489 | 0.72 | — | — | |
| SCHEMBL1115158 | 0.70 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674143-B2 | Synthesis of green ketone intermediate | DSM IP ASSETS, B.V. (NL) | 2014-03-18 | — | — | US | claimed |
| US-20120283476-A1 | SYNTHESIS OF GREEN KETONE INTERMEDIATE | DSM IP ASSETS, B.V. (NL) | 2012-11-08 | — | — | US | claimed |
| WO-2010043522-A1 | SYNTHESIS OF GREEN KETONE INTERMEDIATE | DSM IP ASSETS B.V. (NL) | 2010-04-22 | — | — | WO | claimed |
| EP-4149912-B1 | PROCESS FOR PREPARING DIENE | FIRMENICH & CIE (CH) | 2025-04-30 | — | — | EP | disclosed |
| US-12103898-B2 | Process for preparing diene | FIRMENICH SA (CH) | 2024-10-01 | — | — | US | disclosed |
| US-20230265025-A1 | PROCESS FOR PREPARING DIENE | FIRMENICH SA (CH) | 2023-08-24 | — | — | US | disclosed |
| CN-115916732-A | Process for preparing dienes | 弗门尼舍有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-4149912-A1 | PROCESS FOR PREPARING DIENE | Firmenich SA (CH) | 2023-03-22 | — | — | EP | disclosed |
| EP-3122713-B1 | PROCESS FOR THE PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL)ETHANONE | DSM IP ASSETS BV (NL) | 2019-04-24 | — | — | EP | disclosed |
| EP-3122713-B1 | PROCESS FOR THE PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL)ETHANONE | DSM IP ASSETS BV (NL) | 2019-04-24 | — | — | EP | disclosed |
| CN-106132916-B | The production technology of 1- (5,5- dimethyleyelohexane -1- alkene -1- bases) ethane ketone and 1- (5,5- dimethyleyelohexane -6- alkene -1- bases) ethane ketone | 帝斯曼知识产权资产管理有限公司 | 2018-09-21 | — | — | CN | disclosed |
| EP-1496911-A1 | USE OF A2A ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1434782-A2 | 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF | University of Virginia Patent Foundation (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2004050602-A1 | ESTERS AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2004-06-17 | — | — | WO | disclosed |
| WO-2003086408-A1 | USE OF A2A ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030186926-A1 | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-02 | — | — | US | disclosed |
| WO-2003029264-A2 | 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2003-04-10 | — | — | WO | disclosed |
| US-4289659-A | CYCLOHEXANE DERIVATIVES | FIRMENICH SA (CH) | 1981-09-15 | — | — | US | disclosed |
| US-4264467-A | Cyclic C6 compounds and their use in perfumes | FIRMENICH SA (CH) | 1981-04-28 | — | — | US | disclosed |
| US-4147672-A | Cyclic C6 ketones in perfumes | FIRMENICH SA (CH) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265025-A1 | PROCESS FOR PREPARING DIENE | FDFT1, SQLE, DHPS | ALDH1A1 872/4885 |
| US-12103898-B2 | Process for preparing diene | FDFT1, SQLE, DHPS | ALDH1A1 872/4885 |
| US-20030186926-A1 | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof | ADORA2A, ADORA1, ADORA3 | ALDH1A1 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.